Pioneering Hope: Prof. Dato’ Sri Dr. Mike Chan Illuminates Regenerative Medicine at APPS Conference 2025

A Landmark Gathering for Health Innovation

Kota Kinabalu, Malaysia, July 4 2025 – The 5th Association of Private Practitioners Sabah (APPS) Scientific Conference 2025, held from July 4-6, at the Sabah International Convention Centre (SICC), has been a beacon of medical advancement. Among the distinguished speakers, Prof. Dato’ Sri Dr. Mike Chan, Chairman and Chief Researcher of European Wellness Biomedical Group, captivated attendees with his profound insights into regenerative medicine.

European Wellness, a proud Diamond Sponsor of the event, played a significant role, showcasing cutting-edge advancements in healthcare. Prof. Dr. Mike Chan’s presentation, titled “Treating the Untreatables: Targeted Brain and Organ Precursor Stem Cells in Regenerative Medicine, with Case Studies from Neurodevelopmental and Neurodegenerative to Autoimmune Disorders,” was a highlight, drawing considerable attention from medical professionals and enthusiasts alike.

Unlocking the Body’s Healing Potential

At the heart of European Wellness Biomedical Group’s (EWBG) participation was Prof. Mike Chan, founder and Chairman of the group, widely regarded as a global pioneer in stem cell therapy and anti-aging medicine. With four decades of expertise and over 130 scientific publications, he delivered two highly anticipated keynote sessions that reframed the dialogue around bioregenerative medicine and longevity.

In his talk, Prof. Mike Chan drew from his extensive experience—including contributions to the world’s first stem cell medical textbook (2016) and guidebooks for doctors in anti-aging medicine. “We’re not just extending life—we’re improving its quality,” he said. “Longevity science is about full-body, brain and organ rejuvenation—it’s going to the root cause.”

He emphasized education as a cornerstone of future therapies, citing his most recent 2024 publication on longevity medicine and the importance of empowering regional practitioners through knowledge exchange. “There’s so much more we can achieve through education and strategic training,” Prof. Mike Chan noted. “Especially here in Asia, where demand is growing exponentially.”

Empowering a Healthier Tomorrow

Prof. Mike Chan’s talk demystified complex scientific concepts, making them accessible to everyone. He explained how advanced precursor stem cell therapies can offer new hope for conditions previously thought to be beyond treatment. “Imagine a future where we can help the body repair itself, addressing chronic conditions and even some of the most challenging diseases,” Prof. Chan shared, emphasizing the transformative potential of his work. “Our research focuses on harnessing the body’s innate ability to regenerate, offering a pathway to improved health and quality of life for many.”

His presentation delved into real-world examples, illustrating how targeted organ-and-brain-specific precursor stem cell therapies are making a tangible difference in neurodiverse, neurodegenerative, and autoimmune disorders. This approach represents a paradigm shift in medicine, moving beyond symptom management to address the root causes of illness.

Prof. Mike Chan’s dedication to advancing regenerative medicine is evident in his pioneering efforts. His work with European Wellness continues to push the boundaries of what is possible, offering renewed hope to clients worldwide. The conference served as an excellent platform for sharing these groundbreaking developments and fostering collaboration within the medical community.

Prof. Mike Chan, who owns 46 medical centers worldwide and holds over 50 patents, also serves as a Senator in the German Federal Association for Economic Development and Foreign Trade (BWA)—highlighting his dual role in global healthcare diplomacy and innovation.